
|Articles|November 1, 2012
LNG-IUS may have potential in endometrial cancer
Insertion of a levonorgestrel intrauterine system (LNG-IUS) can reverse abnormal endometrial cell growth, according to the results of a small study in high-risk patients, suggesting that the device may have potential in treatment of women with early-stage endometrial cancer who are not candidates for surgery.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Telehealth expands maternal-fetal medicine access, with Jeffrey Chapa, MD
2
Updated: CMS proposed G-codes for obstetric billing draw concern from ACOG amid coding transition
3
HIV screening, PrEP counseling get stronger ACOG recommendation
4
Biomarker testing for preeclampsia with Lisa A. Bukovac, DO, FACOG
5




